JP2016510040A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016510040A5 JP2016510040A5 JP2015560384A JP2015560384A JP2016510040A5 JP 2016510040 A5 JP2016510040 A5 JP 2016510040A5 JP 2015560384 A JP2015560384 A JP 2015560384A JP 2015560384 A JP2015560384 A JP 2015560384A JP 2016510040 A5 JP2016510040 A5 JP 2016510040A5
- Authority
- JP
- Japan
- Prior art keywords
- pulmonary
- administered
- hypertension
- medicament
- inorganic nitrite
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 claims description 17
- 230000002685 pulmonary effect Effects 0.000 claims description 5
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims description 4
- 230000001746 atrial effect Effects 0.000 claims description 4
- 230000004872 arterial blood pressure Effects 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 210000001147 pulmonary artery Anatomy 0.000 claims description 3
- 230000036772 blood pressure Effects 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims 19
- 208000002815 pulmonary hypertension Diseases 0.000 claims 9
- 239000003795 chemical substances by application Substances 0.000 claims 8
- 206010064911 Pulmonary arterial hypertension Diseases 0.000 claims 6
- 229940079593 drug Drugs 0.000 claims 4
- 206010019280 Heart failures Diseases 0.000 claims 3
- 208000038003 heart failure with preserved ejection fraction Diseases 0.000 claims 3
- 208000004248 Familial Primary Pulmonary Hypertension Diseases 0.000 claims 2
- 208000020875 Idiopathic pulmonary arterial hypertension Diseases 0.000 claims 2
- 208000029523 Interstitial Lung disease Diseases 0.000 claims 2
- 208000008253 Systolic Heart Failure Diseases 0.000 claims 2
- 208000018631 connective tissue disease Diseases 0.000 claims 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical group [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 claims 2
- 206010039710 Scleroderma Diseases 0.000 claims 1
- 230000000747 cardiac effect Effects 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000036593 pulmonary vascular resistance Effects 0.000 claims 1
- 230000035485 pulse pressure Effects 0.000 claims 1
- 230000029058 respiratory gaseous exchange Effects 0.000 claims 1
- 208000023504 respiratory system disease Diseases 0.000 claims 1
- 235000010288 sodium nitrite Nutrition 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361771063P | 2013-02-28 | 2013-02-28 | |
| US61/771,063 | 2013-02-28 | ||
| PCT/US2014/019703 WO2014134585A1 (en) | 2013-02-28 | 2014-02-28 | Inorganic nitrite to improve cardiopulmonary hemodynamics |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019088704A Division JP2019123754A (ja) | 2013-02-28 | 2019-05-09 | 心肺血行動態を改善するための無機亜硝酸塩 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016510040A JP2016510040A (ja) | 2016-04-04 |
| JP2016510040A5 true JP2016510040A5 (enExample) | 2017-03-30 |
| JP6531990B2 JP6531990B2 (ja) | 2019-06-19 |
Family
ID=51428880
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015560384A Active JP6531990B2 (ja) | 2013-02-28 | 2014-02-28 | 心肺血行動態を改善するための無機亜硝酸塩 |
| JP2019088704A Pending JP2019123754A (ja) | 2013-02-28 | 2019-05-09 | 心肺血行動態を改善するための無機亜硝酸塩 |
| JP2022103254A Pending JP2022121544A (ja) | 2013-02-28 | 2022-06-28 | 心肺血行動態を改善するための無機亜硝酸塩 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019088704A Pending JP2019123754A (ja) | 2013-02-28 | 2019-05-09 | 心肺血行動態を改善するための無機亜硝酸塩 |
| JP2022103254A Pending JP2022121544A (ja) | 2013-02-28 | 2022-06-28 | 心肺血行動態を改善するための無機亜硝酸塩 |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US20160008394A1 (enExample) |
| EP (1) | EP2961479A4 (enExample) |
| JP (3) | JP6531990B2 (enExample) |
| CA (1) | CA2902965C (enExample) |
| WO (1) | WO2014134585A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1653978B1 (en) | 2003-07-09 | 2020-06-03 | GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Use of nitrite salts for the treatment of cardiovascular conditions |
| WO2014124256A1 (en) * | 2013-02-07 | 2014-08-14 | The Trustees Of The University Of Pennsylvania | Methods of treating heart failure |
| CA2902965C (en) * | 2013-02-28 | 2023-08-29 | Aires Pharmaceuticals, Inc. | Inorganic nitrite to improve cardiopulmonary hemodynamics |
| WO2018128999A1 (en) * | 2017-01-03 | 2018-07-12 | Cardioxyl Pharmaceuticals, Inc. | Method of administering nitroxyl donating compounds |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4509515A (en) | 1982-02-23 | 1985-04-09 | Fisons Plc | Inhalation device |
| US4889116A (en) | 1987-11-17 | 1989-12-26 | Phospho Energetics, Inc. | Adaptive control of neonatal fractional inspired oxygen |
| ATE376850T1 (de) | 1990-12-05 | 2007-11-15 | Gen Hospital Corp | Vorrichtung zum behandeln einen lungengefässverengung und von asthma |
| US5427797A (en) | 1993-04-06 | 1995-06-27 | Brigham And Women's Hospital | Systemic effects of nitric oxide inhalation |
| JP2004521083A (ja) * | 2000-10-27 | 2004-07-15 | ニトロメッド，インク． | 酸化窒素不足によって特徴づけられる血管疾患の治療方法 |
| EP1653978B1 (en) * | 2003-07-09 | 2020-06-03 | GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Use of nitrite salts for the treatment of cardiovascular conditions |
| US9180140B2 (en) * | 2007-02-26 | 2015-11-10 | Heartbeet Ltd. | Performance enhancing composition and use thereof |
| AU2008219834C1 (en) | 2007-02-26 | 2015-11-12 | Heartbeet Ltd. | New use of nitrites and nitrates and compositions containing these |
| WO2009029836A2 (en) * | 2007-08-31 | 2009-03-05 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Nitrite and nitrite-metheme therapy to detoxify stroma-free hemoglobin based blood substitutes |
| US20120208762A1 (en) | 2009-10-27 | 2012-08-16 | The Board Of Trustees Of The University Of Illinois | Methods of Diagnosing Diastolic Dysfunction |
| GB201020811D0 (en) * | 2010-12-08 | 2011-01-19 | Solvotrin Innovations Ltd | Compounds |
| WO2012142413A2 (en) * | 2011-04-14 | 2012-10-18 | Theravasc Inc. | Nitrite compositions and uses thereof |
| WO2013116194A2 (en) * | 2012-01-30 | 2013-08-08 | O'connell Timothy D | Method of treating or limiting development of heart failure with preserved ejection fraction and tissue fibrosis |
| WO2014124256A1 (en) * | 2013-02-07 | 2014-08-14 | The Trustees Of The University Of Pennsylvania | Methods of treating heart failure |
| CA2902965C (en) * | 2013-02-28 | 2023-08-29 | Aires Pharmaceuticals, Inc. | Inorganic nitrite to improve cardiopulmonary hemodynamics |
-
2014
- 2014-02-28 CA CA2902965A patent/CA2902965C/en active Active
- 2014-02-28 JP JP2015560384A patent/JP6531990B2/ja active Active
- 2014-02-28 US US14/768,198 patent/US20160008394A1/en not_active Abandoned
- 2014-02-28 EP EP14757027.9A patent/EP2961479A4/en not_active Ceased
- 2014-02-28 WO PCT/US2014/019703 patent/WO2014134585A1/en not_active Ceased
-
2018
- 2018-04-16 US US15/954,304 patent/US11219640B2/en active Active
-
2019
- 2019-05-09 JP JP2019088704A patent/JP2019123754A/ja active Pending
-
2021
- 2021-12-02 US US17/540,965 patent/US11986493B2/en active Active
-
2022
- 2022-06-28 JP JP2022103254A patent/JP2022121544A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6466543B2 (ja) | 高濃度の一酸化窒素の投与法 | |
| AU2018394928B2 (en) | Use of inhaled nitric oxide and oxygen for the treatment of pulmonary hypertension | |
| JP2017503801A (ja) | 小児における急性呼吸促迫症候群の治療のための吸入一酸化窒素ガスを使用する方法 | |
| JP2015193657A5 (enExample) | ||
| JP2016516016A5 (enExample) | ||
| JP2017501154A5 (enExample) | ||
| JP2014514271A5 (enExample) | ||
| JP2016510040A5 (enExample) | ||
| MX2015014939A (es) | Nuevo uso de clorhidrato de landiolol en el tratamiento a largo plazo de taquiarritmias e hipertension. | |
| JP2012533542A5 (enExample) | ||
| JP7369523B2 (ja) | 中等度～重度のインフルエンザの処置 | |
| JP2017511307A5 (enExample) | ||
| CN103520161B (zh) | 一种解决长效酰胺类局麻药所致心脏停搏的药物组合 | |
| Ko et al. | Changes in pulmonary artery pressures during ethanol sclerotherapy for arteriovenous malformations: identifying the most vulnerable period | |
| EP3256216B1 (en) | Milrinone composition and method for administering same | |
| Sultan et al. | Cardiovascular effects of prolonged milrinone inhalation in patients with pulmonary hypertension undergoing mitral valve replacement | |
| Van Brantegem et al. | Reversal of a continuous deep neuromuscular blockade with sugammadex in morbidly obese patients: lean body weight or total body weight as dosing scalar?: 9AP4-4 | |
| JP2015512439A5 (enExample) | ||
| Morales | Bradycardia and hypotension: case report | |
| Misumi et al. | Refractory Hypotension after Cardioversion in a Patient with Atrial Fibrillation and Congestive Heart Failure | |
| Williams | Hope for patients with pulmonary hypertension: pulmonary hypertension | |
| Tripathi et al. | Effect of preoxygenation practices on bispectral index and the propofol induction | |
| Kandasamy | Refractory ventricular tachycardia: case report | |
| Ghatak | Left ventricular failure and left ventricular inferior wall hypokinesia: case report | |
| Akinci et al. | A Case of Accidental Injection of Epinephrine (Epipen®)/Kazara Epinefrin (Epipen®) Enjeksiyonu Olgusu |